HC Wainwright maintains Definium Therapeutics $70 price target
Benzinga reported that HC Wainwright & Co. maintained a $70.00-per-share price target for Definium Therapeutics.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.